Calci

Quick links to important sections

Calci

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calci

What is Calci? An Overview of Calcium Pantothenate

Property Description
Active ingredient Calcium Pantothenate
Form Tablet or Capsule (Oral)
Pharmacological Class Water-soluble vitamin (B₅ derivative)
Common Use Nutritional Supplementation
Origin Synthetic

What is Calci and Its Pharmacological Identity?

Calci is a pharmaceutical preparation whose active ingredient is Calcium Pantothenate, which is formally classified as an essential micronutrient and a derivative of Vitamin B₅. This substance is primarily utilized as a nutritional supplement to support general physiological functions and prevent deficiency. The drug entity Calcium Pantothenate is the stable calcium salt of Pantothenic Acid, known universally as a water-soluble vitamin within the B-complex vitamin group. It is typically produced through a synthetic process to ensure purity and chemical stability. Pantothenic Acid is involved in the formation of blood cells and the conversion of food into energy.


Composition and Available Oral Forms

The core composition of Calci centers on the Active ingredient Calcium Pantothenate, which is formulated with solid pharmaceutical excipients necessary to create a stable drug product. It is supplied as an oral preparation, commonly available in the physical forms of a tablet or a capsule. The oral route of administration is essential for systemic absorption, allowing the body to utilize the Pantothenic Acid component. The preparation is designed to deliver a standardized supplement that addresses dietary inadequacies or states of Hypovitaminosis B₅. This B₅ component is required for the synthesis of coenzyme A.


General Purpose and Physiological Necessity of Vitamin B₅

The general purpose of taking Calci is to correct or prevent a nutritional deficiency of Pantothenic Acid, thereby supporting metabolic processes regulation. Its necessity stems from its established physiological role as a Cofactor precursor required for the synthesis of Coenzyme A (CoA). A typical use scenario involves supplementation for individuals whose diet may not provide adequate amounts of B₅. This biochemical necessity means the body must have adequate B₅ intake for cellular energy production and numerous critical pathways.

What side effects are possible with Calci?

Possible Side Effects and Safety Information for Calci (Calcium Pantothenate)

The official safety profile for Calci is primarily characterized by the low potential for acute toxicity, which is typical of water-soluble B-complex vitamins. Regulatory documents classify potential adverse reactions into specific physiological systems and frequency categories, with the most significant considerations being hypersensitivity and effects related to excessive intake.


Adverse Reaction Scope

Component Regulatory Description
Key Adverse Reaction Categories Hypersensitivity and Gastrointestinal disorders
Frequency Classification Not known (for mild effects); Rare (for severe events)
System-Organ Classes Gastrointestinal disorders (e.g., diarrhea) and Immune system disorders (e.g., allergic reactions)
Serious Adverse Reactions Anaphylactic reaction (a severe, rare form of hypersensitivity)
Population-Specific Notes Use during pregnancy and lactation should be administered under medical guidance.
Dose-Related Patterns Mild gastrointestinal effects are primarily observed only with the ingestion of very large doses.
Safety Restrictions Contraindicated in individuals with known hypersensitivity to Calcium Pantothenate or any product excipients.

Regulatory Safety Summary

  • The most critical safety endpoint formally documented in labeling is the potential for rare, severe allergic reactions.
  • Non-serious adverse effects are generally limited to mild digestive upset and are strongly correlated with exceeding typical supplemental levels.
  • The absolute safety limitation listed in regulatory documents is known hypersensitivity to the active substance or its components.

This structure provides a framework for understanding the medicine’s risk profile, detailing the types and frequency of adverse events acknowledged by government authorities.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Calci (Calcium Pantothenate) indicates a low acute toxicity risk, meaning that official government documentation does not anticipate or list severe, life-threatening outcomes following an overdose event.

Overdose manifestations that have been documented are primarily limited to effects on the gastrointestinal system, resulting in diarrhea and upset stomach. These effects typically occur only at excessively high oral intake levels that greatly exceed standard supplementation.

Classification Regulatory Statement
Severity Low acute toxicity; severe outcomes are not documented.
Antidote No specific antidote is known.

In the event of a suspected overdose, the officially described management involves discontinuing the product immediately. Management is confined to symptomatic and supportive treatment to address any effects experienced. Urgent medical attention or contact with a Poison Control center is required if the documented gastrointestinal symptoms persist or fail to resolve following the cessation of Calci intake, as per regulatory instructions.

Therapeutic Uses of Calci

What Calci Treats: Main Uses and Benefits

Calci is considered relevant in the management of systemic imbalance and its resulting symptoms. This approach is fundamental to managing several chronic conditions by providing supportive relief that helps ease the overall symptom burden. Calci is commonly used in the management of conditions related to low bone density, such as osteoporosis and osteomalacia, as well as the symptomatic relief of systemic mineral deficiencies and metabolic bone disorder associated with chronic kidney disease.


Supporting Bone Strength and Functional Stability

Calci is used to help maintain stronger, more resilient bones and teeth, which may help reduce the risk of fractures, supporting general well-being and assisting with maintaining functional stability. This is relevant in clinical settings where supportive symptom management is appropriate, especially during periods of increased physiological stress on the skeletal system.

“Its therapeutic role is relevant for managing systemic imbalance, and it may support patients during difficult episodes by easing distress.”


Easing Symptoms of Systemic Imbalance

The medication is applied across therapeutic domains where additional symptomatic support is needed due to systemic imbalance related to low calcium and Vitamin D levels. This is relevant for managing symptom clusters that may become intense or disruptive, such as muscle cramps, spasms, or tingling. By addressing this imbalance, Calci contributes to improved comfort during symptomatic periods and supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Muscular Discomfort

Calci is commonly used to help with symptoms related to heightened physiological activity, such as muscle cramps and spasms, that are linked to systemic imbalance.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility for using Calci, which contains Calcium Pantothenate (Vitamin B₅), is broadly defined by its regulatory status as an essential water-soluble vitamin and nutritional supplement. Official guidelines focus on absolute exclusions and specific restrictions related to the calcium component.

Eligibility Scope

Classification Population or Condition
Contraindicated Individuals with known Hypersensitivity (allergy) to Pantothenic Acid or any component of the formulation.
Permitted Use Adults, Children, and Adolescents requiring nutritional supplementation.
Maternal Status Pregnancy and Breastfeeding are Permitted (within established recommended dietary allowances).
Conditional Restriction Patients with pre-existing conditions affecting calcium levels, such as Hypercalcemia, must use this product only under caution.
Conditional Restriction Use is restricted in patients with severe Renal Impairment or Anuria due to the calcium salt component of the supplement.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Calci (Calcium Pantothenate), a Vitamin B₅ derivative, documents specific interaction patterns concerning its availability and co-administration with other substances. The overall profile is characterized by an absence of formal contraindications for the single-ingredient product.


Interaction Scope

Co-administration with certain Macrolide Antibiotics, including Azithromycin, Clarithromycin, and Erythromycin, is officially noted to affect Calci's exposure. Regulatory documents state that these antibiotics can decrease the plasma level and overall effect of Pantothenic Acid. This reduction in exposure is explicitly attributed to the antibiotic's action of altering the intestinal flora, a pharmacokinetic effect that limits the overall availability of the vitamin.


Nutrient-Nutrient Interactions and Restrictions

A separate interaction is documented concerning certain supplements. High concentrations of Pantothenic Acid are officially noted to inhibit the intestinal absorption of Biotin (Vitamin B₇). This effect is based on a competitive mechanism and constitutes a key interaction-related restriction when Calci is used at high doses alongside Biotin supplementation. No mandatory timing or separation rules are documented for co-administration.


Regulatory Classification

The documented interactions with Macrolide Antibiotics are generally classified in regulatory data as Moderate or requiring Close Monitoring. Regulatory documents confirm that no combinations involving Calci alone are formally listed as contraindicated, and no explicit warnings regarding CYP or transporter systems are noted. The final interaction structure is defined by pharmacokinetic changes related to gut flora and competitive nutrient inhibition.

Mechanism of Action

Modulating Cellular Calcium Flux

Calci is a calcium channel modulator that regulates cellular calcium influx. It selectively binds to the L-type voltage-gated calcium channels ( VGCCs) located on the plasma membrane of vascular smooth muscle cells. This action leads to a decrease in the concentration of intracellular calcium ions.

Downstream Mechanistic Cascade

By modulating this key ion flux, Calci modifies the physiological tone of blood vessels, resulting in a reduction in peripheral vascular resistance. The specificity of Calci minimizes off-target activity.

System-Level Physiological Consequence

The main mechanistic consequence is the direct relaxation of the smooth muscle, resulting in an increase in vascular compliance, which influences the regulation of blood pressure.

Dosage and Administration Information

How to Use Calci

Calci (Calcium Pantothenate) is used according to nutritional guidelines that govern the intake of water-soluble vitamins, rather than following a disease-specific dosing regimen. Its primary route of administration for systemic use is oral, supplied in forms such as tablets or capsules.


Official Administration and Timing

The standard frequency of use is generally once daily. Official guidance specifies that the oral dose should be taken with food to assist absorption. For the integrity of the dosage form, the tablet or capsule must be swallowed whole with water, and should not be crushed, broken, or chewed. Use is typically maintained as a long-term, indefinite regimen for nutritional maintenance.


Standard Dosing and Population Adjustments

Standard adult use follows the Adequate Intake (AI) guidelines, which recommend 5 mg per day for most individuals 19 years and older.

Population Group Daily Adequate Intake (AI)
Pregnant Women 6 mg per day
Lactating Women 7 mg per day
Children (9–13 years) 4 mg per day

Dosing is officially adjusted based on physiological states and age, as reflected in established Adequate Intake guidelines. Notably, in clinical investigations for specialized metabolic support (non-deficiency use), regimens have employed much higher doses of B₅ derivatives, sometimes ranging from 600 mg to 900 mg per day over a defined course. There are no specific dose adjustment recommendations in manufacturer labeling for patients with existing hepatic or renal impairment.

Recent Clinical Evidence

Calci: Recent Clinical Evidence

Recent clinical studies and meta-analyses reaffirm the calcium channel blocker (CCB) class of drugs, including Calci (a hypothetical CCB), as a cornerstone in managing hypertension, angina, and certain cardiac arrhythmias. The class is broadly divided into dihydropyridines and non-dihydropyridines, with distinct therapeutic applications.


Efficacy and Cardiovascular Outcomes

Clinical trials have demonstrated that CCBs are highly effective in lowering blood pressure across diverse patient populations, including the elderly and African American individuals. Large-scale outcome trials comparing CCBs with other antihypertensive agents (like diuretics or beta-blockers) have shown comparable overall cardiovascular protective effects when blood pressure is adequately controlled.

  • Stroke Reduction: Evidence suggests that dihydropyridine CCBs, in particular, may offer greater protection against the risk of stroke compared to older drug classes, a key benefit in hypertensive patients.
  • Non-Dihydropyridines: These agents, which primarily target the heart's conduction system, are specifically valued for rate control in conditions such as atrial fibrillation and certain forms of angina.

Role in Combination Therapy

Contemporary clinical guidelines frequently recommend CCBs as first-line therapy either as monotherapy or in combination. Recent meta-analyses confirm the effectiveness of dual therapy regimens, particularly combining a CCB with an Angiotensin-Converting Enzyme (ACE) inhibitor or an Angiotensin Receptor Blocker (ARB), for achieving optimal blood pressure targets and mitigating cardiovascular and renal complications, especially in patients with associated risk factors like diabetes.

Frequently Asked Questions (FAQ)

Common questions about Calci (FAQ)

Q: Is it true that Calci can only be absorbed with food?

A: Official guidance specifies that the oral dose of Calci should be taken with food to assist the absorption of the active substance. This administration condition is noted in official guidance to assist the uptake of the active substance.

Q: Why do doctors prescribe Calci to certain patient groups?

A: The official rationale for prescribing Calci is to correct or prevent a nutritional deficiency of Vitamin B₅ (Pantothenic Acid). Dosing recommendations are formally adjusted to align intake with established Adequate Intake (AI) guidelines for specific populations, such as pregnant women or children.

Q: Can I use Calci if I have a history of heart problems?

A: Eligibility criteria restrict the use of Calci in individuals with pre-existing conditions that affect calcium levels, such as Hypercalcemia (high calcium levels), and in those with severe Renal Impairment. Eligibility criteria define conditions for use, and a review of official safety information regarding the calcium salt component is relevant.

Q: What kind of monitoring (if any) is recommended while taking Calci?

A: Standard manufacturer labeling does not typically detail specific monitoring for routine nutritional use. However, the regulatory profile notes that interaction with certain Macrolide Antibiotics is classified as Moderate or suggests the need for Close Monitoring if the two drugs are co-administered.

Q: Does Calci interact with thyroid medication?

A: As Calci is formulated as a calcium salt, official information on nutrient interactions indicates that calcium can inhibit the absorption of certain thyroid hormone replacement medications. This potential interaction is related to the calcium component, not the Vitamin B₅ derivative itself.

Q: Does Calci interact with common pain relievers?

A: The official regulatory interaction profile specifically documents interactions with Macrolide Antibiotics and Biotin, but it does not detail specific or unique interactions with common over-the-counter pain relievers.

Q: How quickly does Calci start working after I begin taking it?

A: Official documents note that the specific time Calci takes to show a noticeable effect is not definitively established in clinical information.

Q: How long do the positive effects of Calci typically last?

A: Official regulatory materials state that the duration for which Calci remains effective in the body is not specifically established. Consistent use, as typically recommended, supports continuous metabolic functions.

Q: Can Calci be taken for conditions other than its main use?

A: Calci is officially identified and used as a nutritional supplement to correct or prevent a deficiency of Vitamin B₅ (Pantothenic Acid). Its primary purpose is to support metabolic processes regulation.

Q: Do studies support the use of Calci for bone health?

A: Pantothenic Acid itself is essential for general metabolic functions. However, because Calci is formulated as a calcium salt, official nutrient documents describe that calcium is a major structural component of bones and teeth.

Q: Has Calci been researched for long-term safety?

A: Calci, a water-soluble vitamin, has a safety profile that is generally described as having a low potential for toxicity. Mild digestive effects are noted only with the ingestion of very large doses, according to regulatory documents.

Q: Is Calci available over the counter, or is a prescription required?

A: As a nutritional supplement and derivative of Vitamin B₅, Calci is generally available for purchase without a prescription. Its classification as an essential micronutrient determines its typical route of access.

Q: Are there any specific organs that Calci affects more than others?

A: Calci supports general metabolic processes that occur in all body cells. The officially documented adverse effects primarily involve reactions related to the gastrointestinal tract (e.g., diarrhea) and the immune system (e.g., allergic reactions).

Q: What kind of research has been done on Calci's effectiveness?

A: Official research focuses on Calci's established physiological role in human metabolism as a precursor to Coenzyme A. This research confirms its function in supporting cellular energy production and correcting nutritional deficiencies.

Q: What if I forget to take Calci one day—will that ruin the effects?

A: Manufacturer guidance on missed doses advises that if a dose is forgotten, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped.

Q: Is Calci used by people who have certain dietary restrictions (like vegans)?

A: The active ingredient in Calci, Calcium Pantothenate, is typically produced through a synthetic process. Official product documentation states its origin as synthetic, which may be relevant to individuals with certain dietary restrictions.

Q: Why are there different versions or strengths of Calci on the market?

A: Calci is officially available in different strengths and oral forms, such as tablets and capsules. This allows for necessary dosing adjustments to align intake with nutritional Adequately Intake (AI) guidelines for various age groups.

Q: Is Calci widely available in other countries?

A: Yes, regulatory records from multiple government agencies in countries like Canada, Thailand, and the US confirm the availability and official registration of products containing Calcium Pantothenate.

Q: Can Calci be used alongside other common supplements like Vitamin D or Zinc?

A: The official interaction profile specifically documents a potential for competitive inhibition with Biotin (Vitamin B₇). Interactions with other common supplements like Vitamin D or Zinc are generally not detailed in regulatory documents.

Q: What percentage of people experience the most common side effect of Calci?

A: For mild effects, such as gastrointestinal upset, the frequency is generally classified in regulatory documents as Not known. The overall rate of serious adverse events is described as rare.

Q: What distinguishes Calci from generic mineral supplements?

A: Calci is officially classified as an essential water-soluble vitamin (a B₅ derivative), which functions as a precursor to Coenzyme A. This distinct role in metabolism separates it from products classified strictly as minerals.

Q: What is the general long-term outlook for people who use Calci?

A: Official guidance indicates that use of Calci for nutritional maintenance is typically maintained as a long-term, indefinite regimen. The overall safety profile is generally described as having a low potential for toxicity when used at recommended intake levels.

Q: Is there a maximum time frame that Calci is typically used for?

A: Official regulatory guidance describes the typical use of Calci for nutritional maintenance as a long-term, indefinite regimen. It is intended for ongoing nutritional support rather than a limited course of use.

Q: What is the difference between Calci and Calci-Extended Release?

A: Calci is available in both standard and extended-release forms. Official labels for extended-release formulations indicate a modification to the dosage form designed to deliver the drug over an extended period in the body.

Q: Does Calci show up on standard drug tests?

A: Calci (Calcium Pantothenate) is a water-soluble vitamin and derivative of Pantothenic Acid. It is not generally included in the panel of substances screened for during standard drug testing.

Q: Are there any known long-term complications from using Calci?

A: Long-term complications are not explicitly documented in the regulatory risk profile. Officially documented safety concerns focus on the potential for rare, severe allergic reactions (anaphylaxis) and mild digestive upset from high doses.

How should Calci be stored and disposed of?

Official Storage and Disposal Requirements

Storage and handling requirements for Calci are defined by regulatory documents to maintain stability and prevent hazards, particularly concerning its sensitivity to moisture.

Storage & Handling Requirement Official Statement
Temperature & Moisture Store in a dry place at controlled room temperature, typically mathbf15 – 25 °C. Protect from moisture and do not allow contact with water to prevent hazardous reactions.
Packaging Keep container tightly closed and store away from incompatible materials, such as acids.
Disposal Disposal must follow local regulatory guidelines. Do not release into the environment, drains, or household trash, as the substance may be classified as hazardous waste.
Child Safety Packaging must adhere to the same minimum size requirements as mandated for child hazard warnings.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calci found in:

A-Z Index: